Cheng-hsu Wang
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment.
Journal: Asia-Pacific journal of oncology nursing
Published: December 09, 2025
Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 04, 2023
A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 29, 2023
Transdermal buprenorphine improves overall quality of life and symptom severity in cancer patients with pain.
Journal: Journal of clinical nursing
Published: January 03, 2022
Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE).
Journal: Asia-Pacific journal of clinical oncology
Published: July 21, 2021
Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy.
Journal: Diagnostics (Basel, Switzerland)
Published: May 27, 2021
Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: December 09, 2020
Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps.
Journal: Annals of surgical oncology
Published: November 09, 2020
Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage.
Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage.
Journal: Journal of clinical medicine
Published: March 04, 2020
Last Updated: 09/26/2026